Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
The Core Decision (Made Before Hour 1) The side effect is real, serious, and known to me now. Patients are currently taking this drug without informed consent about a ~1-in-8,000 liver failure risk. Everything else — stock price, board pressure, legal exposure — is secondary.Read the full answer
Hour-by-Hour Action Plan: 48 Hours to Board Meeting Guiding Principle: Patient safety is non-negotiable. Transparency, even when painful, is the only sustainable path. The goal is to act with speed, integrity, and strategic precision to protect patients, the company’s long-term viability, and regulatory trust.Read the full answer